BRUIN CLL-313: Randomized Phase III Trial of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Journal:

Journal of Clinical Oncology

Published:

2025-12-10

DOI:

10.1200/jco-25-02380

Affiliations:

16

Authors:

21

Go to article

Institutions	Authors	Share
Lilly, United States of America (USA)	6.000000	0.29
Nagoya City University, Japan	1.000000	0.05
Medical University of Plovdiv, Bulgaria	1.000000	0.05
Aidport Clinical Trials Hospital, Poland	1.000000	0.05
Linkou Chang Gung Memorial Hospital, Chang Gung Medical Foundation, Taiwan	1.000000	0.05
Seoul St. Mary's Hospital, South Korea	1.000000	0.05
University of Perugia, Italy	1.000000	0.05
Wroclaw Medical University, Poland	1.000000	0.05
Maria Sklodowska-Curie National Research Institute of Oncology, Poland	1.000000	0.05
Hospital Amaral Carvalho, Brazil	1.000000	0.05
Liverpool Hospital, Australia	1.000000	0.05
Salzburger Landeskliniken (SALK), Austria	1.000000	0.05
Masaryk University (MU), Czech Republic	1.000000	0.05
HM Hospitales, Spain	1.000000	0.05
Clinical Research Alliance, United States of America (USA)	1.000000	0.05
Nicolaus Copernicus University in Toruń (NCU), Poland	1.000000	0.05

Interested in Cardiovascular Medicine and Haematology?